WHO ICTRP trial
Preventing lifelong changes and complaints of the leg after a clot has formed in…
EUCTR2020-000749-15-NL · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2020-000749-15-NL |
|---|---|
| Public title | Preventing lifelong changes and complaints of the leg after a clot has formed in the vein of the leg with an additional medincine |
| Scientific title | Resolution Enhancement by a Supplemental Open-Label Venoactive drug for Eight weeks in Deep Vein Thrombosis - The RESOLVE-DVT study |
| Primary sponsor | Academisch ziekenhuis Maastricht |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Netherlands |
| Conditions | Post-thrombotic syndrome;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] |
| Interventions | Trade Name: Venoruton Product Name: Venoruton Pharmaceutical Form: Tablet |
| Registration date | May 18, 2020 |
| Target size | 44 |
| Secondary IDs | NL73142.068.20 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: